200 related articles for article (PubMed ID: 23128675)
1. Genetic analysis of polymorphisms in dopamine receptor and transporter genes for association with smoking among cancer patients.
Gordiev M; Engstrom PF; Khasanov R; Moroshek A; Sitdikov R; Dgavoronkov V; Schnoll RA
Eur Addict Res; 2013; 19(2):105-11. PubMed ID: 23128675
[TBL] [Abstract][Full Text] [Related]
2. Influences of polymorphic variants of DRD2 and SLC6A3 genes, and their combinations on smoking in Polish population.
Sieminska A; Buczkowski K; Jassem E; Niedoszytko M; Tkacz E
BMC Med Genet; 2009 Sep; 10():92. PubMed ID: 19761593
[TBL] [Abstract][Full Text] [Related]
3. Association between dopaminergic polymorphisms and borderline personality traits among at-risk young adults and psychiatric inpatients.
Nemoda Z; Lyons-Ruth K; Szekely A; Bertha E; Faludi G; Sasvari-Szekely M
Behav Brain Funct; 2010 Jan; 6():4. PubMed ID: 20205808
[TBL] [Abstract][Full Text] [Related]
4. Genetic variation in dopamine pathways differentially associated with smoking progression in adolescence.
Laucht M; Becker K; Frank J; Schmidt MH; Esser G; Treutlein J; Skowronek MH; Schumann G
J Am Acad Child Adolesc Psychiatry; 2008 Jun; 47(6):673-681. PubMed ID: 18434921
[TBL] [Abstract][Full Text] [Related]
5. Parental smoke exposure and the development of nicotine craving in adolescent novice smokers: the roles of DRD2, DRD4, and OPRM1 genotypes.
Kleinjan M; Engels RC; DiFranza JR
BMC Pulm Med; 2015 Oct; 15():115. PubMed ID: 26449981
[TBL] [Abstract][Full Text] [Related]
6. The impact of genetic variation in DRD2 and SLC6A3 on smoking cessation in a cohort of participants 1 year after enrollment in a lung cancer screening study.
Styn MA; Nukui T; Romkes M; Perkins K; Land SR; Weissfeld JL
Am J Med Genet B Neuropsychiatr Genet; 2009 Mar; 150B(2):254-61. PubMed ID: 18563706
[TBL] [Abstract][Full Text] [Related]
7. DRD2/ANKK1 TaqI polymorphism and smoking behavior of Egyptian male cigarette smokers.
Radwan GN; El-Setouhy M; Mohamed MK; Hamid MA; Azem SA; Kamel O; Israel E; Loffredo CA
Nicotine Tob Res; 2007 Dec; 9(12):1325-9. PubMed ID: 18058350
[TBL] [Abstract][Full Text] [Related]
8. Genetic influence of dopamine receptor, dopamine transporter, and nicotine metabolism on smoking cessation and nicotine dependence in a Japanese population.
Ohmoto M; Takahashi T; Kubota Y; Kobayashi S; Mitsumoto Y
BMC Genet; 2014 Dec; 15():151. PubMed ID: 25526961
[TBL] [Abstract][Full Text] [Related]
9. Association analyses for dopamine receptor gene polymorphisms and weight status in a longitudinal analysis in obese children before and after lifestyle intervention.
Roth CL; Hinney A; Schur EA; Elfers CT; Reinehr T
BMC Pediatr; 2013 Nov; 13():197. PubMed ID: 24283216
[TBL] [Abstract][Full Text] [Related]
10. Distinct haplogenotypes of the dopamine D2 receptor gene are associated with non-smoking behaviour and daily cigarette consumption.
Wernicke C; Reese J; Kraschewski A; Winterer G; Rommelspacher H; Gallinat J
Pharmacopsychiatry; 2009 Mar; 42(2):41-50. PubMed ID: 19308877
[TBL] [Abstract][Full Text] [Related]
11. Multivariate analysis of dopaminergic gene variants as risk factors of heroin dependence.
Vereczkei A; Demetrovics Z; Szekely A; Sarkozy P; Antal P; Szilagyi A; Sasvari-Szekely M; Barta C
PLoS One; 2013; 8(6):e66592. PubMed ID: 23840506
[TBL] [Abstract][Full Text] [Related]
12. [A pharmacogenetic analysis of dopaminergic and opioidergic genes in opioid addicts treated with the combination of naltrexone and guanfacine].
Kibitov АО; Krupitsky ЕМ; Blokhina ЕА; Verbitskaya ЕV; Brodyansky VМ; Alekseeva NP; Bushara NМ; Yaroslavtseva ТS; Palatkin VY; Masalov DV; Burakov АМ; Romanova ТN; Sulimov GY; Grinenko AY; Kosten Т; Nielsen D; Zvartau EE
Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(11. Vyp. 2):36-48. PubMed ID: 28300812
[TBL] [Abstract][Full Text] [Related]
13. Genetic polymorphisms in the dopamine-2 receptor (DRD2), dopamine-3 receptor (DRD3), and dopamine transporter (SLC6A3) genes in schizophrenia: Data from an association study.
Sáiz PA; García-Portilla MP; Arango C; Morales B; Arias B; Corcoran P; Fernández JM; Alvarez V; Coto E; Bascarán MT; Bousoño M; Fañanas L; Bobes J
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):26-31. PubMed ID: 19766158
[TBL] [Abstract][Full Text] [Related]
14. The role of dopamine transporter (SLC6A3) and dopamine D2 receptor/ankyrin repeat and kinase domain containing 1 (DRD2/ANKK1) gene polymorphisms in personality traits.
Kazantseva A; Gaysina D; Malykh S; Khusnutdinova E
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):1033-40. PubMed ID: 21354244
[TBL] [Abstract][Full Text] [Related]
15. Association study of the SLC6A3 VNTR (DAT) and DRD2/ANKK1 Taq1A polymorphisms with alcohol dependence in a population from northeastern Brazil.
Vasconcelos AC; Neto Ede S; Pinto GR; Yoshioka FK; Motta FJ; Vasconcelos DF; Canalle R
Alcohol Clin Exp Res; 2015 Feb; 39(2):205-11. PubMed ID: 25684044
[TBL] [Abstract][Full Text] [Related]
16. Smoking Genes: A Case-Control Study of Dopamine Transporter Gene (
Ruzilawati AB; Islam MA; Muhamed SKS; Ahmad I
Biomolecules; 2020 Dec; 10(12):. PubMed ID: 33287325
[TBL] [Abstract][Full Text] [Related]
17. Lack of association between the dopamine D2 receptor gene allele DRD2*A1 and cigarette smoking in a United Kingdom population.
Singleton AB; Thomson JH; Morris CM; Court JA; Lloyd S; Cholerton S
Pharmacogenetics; 1998 Apr; 8(2):125-8. PubMed ID: 10022750
[TBL] [Abstract][Full Text] [Related]
18. Pharmacogenetic clinical trial of sustained-release bupropion for smoking cessation.
David SP; Brown RA; Papandonatos GD; Kahler CW; Lloyd-Richardson EE; Munafò MR; Shields PG; Lerman C; Strong D; McCaffery J; Niaura R
Nicotine Tob Res; 2007 Aug; 9(8):821-33. PubMed ID: 17654295
[TBL] [Abstract][Full Text] [Related]
19. Association between polymorphisms of DRD2 and DRD4 and opioid dependence: evidence from the current studies.
Chen D; Liu F; Shang Q; Song X; Miao X; Wang Z
Am J Med Genet B Neuropsychiatr Genet; 2011 Sep; 156B(6):661-70. PubMed ID: 21714067
[TBL] [Abstract][Full Text] [Related]
20. [Family based association study of DRD1, DRD2, DRD3, DRD4, DAT, COMT gene polymorphism in schizophrenia].
Paweł K; Hauser J; Skibińska M; Szczepankiewicz A; Dmitrzak-Weglarz M; Gorzkowska K; Pawlak J; Czerski PM
Psychiatr Pol; 2010; 44(3):405-13. PubMed ID: 20672519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
